Glaxo Unloads Lucozade, Ribena Nutritional Beverages
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline’s latest consumer business divestment, of Lucozade sports beverages and Ribena fruit drinks, reflects the company’s focus on pharmaceuticals and emerging markets, between which the beverage brands were somewhat lost.
You may also be interested in...
Advertising Regulation In Brief: NAD flags ad labeled “news”
NAD flags ad labeled “news”; ASA nixes Lucozade “better than water” claims; Oxford Biolabs fails to substantiate claims; Naked Juice trips on health claims rewrite; and Vitabotics substantiates Visionace claims.
Advertising Regulation In Brief: NAD flags ad labeled “news”
NAD flags ad labeled “news”; ASA nixes Lucozade “better than water” claims; Oxford Biolabs fails to substantiate claims; Naked Juice trips on health claims rewrite; and Vitabotics substantiates Visionace claims.
Sales & Earnings In Brief
Sanofi now world’s No. 3 OTC player; Glaxo weighs Lucozade energy drink divestment; NBTY wraps Balance Bar integration; Vicks launches in Europe boost Teva OTC business; flu trend breeds cautious optimism for Prestige Brands; USANA and Nu Skin face tough times for multilevel marketers.